<?xml version="1.0" encoding="UTF-8"?>
<ref id="B161-molecules-25-03846">
 <label>161.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Siemann</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Chaplin</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Walicke</surname>
    <given-names>P.A.</given-names>
   </name>
  </person-group>
  <article-title>A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)</article-title>
  <source>Expert Opin. Investig. Drugs</source>
  <year>2009</year>
  <volume>18</volume>
  <fpage>189</fpage>
  <lpage>197</lpage>
  <pub-id pub-id-type="doi">10.1517/13543780802691068</pub-id>
  <?supplied-pmid 19236265?>
  <pub-id pub-id-type="pmid">19236265</pub-id>
 </element-citation>
</ref>
